Cochlear Limited's (ASX:COH) Shares May Have Run Too Fast Too Soon
Jul 16
Have your own idea? Try our Stock Screener
Australian (ASX) Healthcare Sector Analysis
UpdatedJul 19, 2025
DataAggregated Company Financials
Companies133
- 7D4.5%
- 3M11.3%
- 1Y-3.2%
- YTD-1.7%
Over the last 7 days, the Healthcare industry has risen 4.5%, driven by gains from CSL of 6.8%. In the past year, the industry is down 3.2%. Looking forward, earnings are forecast to grow by 18% annually.
Sector Valuation and Performance
Has the Australian Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 19 Jul 2025 | AU$270.7b | AU$71.7b | AU$4.3b | 29.6x | 63.4x | 3.8x |
| Mon, 16 Jun 2025 | AU$254.7b | AU$71.8b | AU$4.3b | 25.8x | 59.4x | 3.5x |
| Wed, 14 May 2025 | AU$254.2b | AU$70.6b | AU$4.9b | 27.2x | 52x | 3.6x |
| Fri, 11 Apr 2025 | AU$243.8b | AU$71.6b | AU$5.0b | 26.3x | 48.4x | 3.4x |
| Sun, 09 Mar 2025 | AU$261.1b | AU$71.1b | AU$4.9b | 28.9x | 53.1x | 3.7x |
| Tue, 04 Feb 2025 | AU$250.9b | AU$69.1b | AU$3.4b | 26.6x | 73.7x | 3.6x |
| Thu, 02 Jan 2025 | AU$244.6b | AU$69.1b | AU$3.4b | 25.4x | 72.2x | 3.5x |
| Sat, 30 Nov 2024 | AU$248.2b | AU$68.0b | AU$3.2b | 26.8x | 77.6x | 3.7x |
| Mon, 28 Oct 2024 | AU$242.2b | AU$67.6b | AU$3.1b | 26x | 77x | 3.6x |
| Wed, 25 Sep 2024 | AU$236.9b | AU$66.6b | AU$3.0b | 27.3x | 78.4x | 3.6x |
| Fri, 23 Aug 2024 | AU$243.5b | AU$64.2b | AU$3.2b | 36.7x | 77.1x | 3.8x |
| Sun, 21 Jul 2024 | AU$244.6b | AU$62.7b | AU$2.6b | 33.1x | 93.8x | 3.9x |
| Tue, 18 Jun 2024 | AU$232.2b | AU$63.2b | AU$2.7b | 32.5x | 87.4x | 3.7x |
| Thu, 16 May 2024 | AU$227.0b | AU$61.1b | AU$2.6b | 26.5x | 87x | 3.7x |
| Sat, 13 Apr 2024 | AU$223.9b | AU$61.7b | AU$2.7b | 25.8x | 83.6x | 3.6x |
| Mon, 11 Mar 2024 | AU$225.8b | AU$61.4b | AU$2.6b | 25.7x | 86.5x | 3.7x |
| Wed, 07 Feb 2024 | AU$230.6b | AU$59.3b | AU$3.1b | 25.4x | 75.4x | 3.9x |
| Fri, 05 Jan 2024 | AU$224.3b | AU$60.0b | AU$2.8b | 24.9x | 80.8x | 3.7x |
| Sun, 03 Dec 2023 | AU$206.4b | AU$60.1b | AU$2.8b | 24.8x | 73.1x | 3.4x |
| Tue, 31 Oct 2023 | AU$184.6b | AU$61.2b | AU$3.0b | 24x | 61.9x | 3x |
| Thu, 28 Sep 2023 | AU$200.9b | AU$61.3b | AU$2.9b | 24.9x | 68.4x | 3.3x |
| Sat, 26 Aug 2023 | AU$207.7b | AU$61.5b | AU$2.9b | 24.9x | 71.1x | 3.4x |
| Mon, 24 Jul 2023 | AU$212.2b | AU$57.5b | AU$2.9b | 27x | 74.1x | 3.7x |
| Wed, 21 Jun 2023 | AU$221.4b | AU$57.4b | AU$2.8b | 25.7x | 78x | 3.9x |
| Fri, 19 May 2023 | AU$230.4b | AU$57.8b | AU$2.9b | 27.7x | 79.8x | 4x |
| Sun, 16 Apr 2023 | AU$231.5b | AU$57.1b | AU$2.9b | 28.5x | 80.9x | 4.1x |
| Tue, 14 Mar 2023 | AU$218.5b | AU$57.2b | AU$2.9b | 24.9x | 75.9x | 3.8x |
| Thu, 09 Feb 2023 | AU$229.8b | AU$55.1b | AU$3.9b | 24.9x | 58.5x | 4.2x |
| Sat, 07 Jan 2023 | AU$213.5b | AU$55.4b | AU$4.0b | 25.2x | 53.2x | 3.9x |
| Mon, 05 Dec 2022 | AU$227.8b | AU$55.6b | AU$4.0b | 26.5x | 56.3x | 4.1x |
| Wed, 02 Nov 2022 | AU$216.0b | AU$56.5b | AU$4.2b | 26.7x | 51.3x | 3.8x |
| Fri, 30 Sep 2022 | AU$214.0b | AU$56.2b | AU$4.2b | 29.9x | 50.8x | 3.8x |
| Sun, 28 Aug 2022 | AU$225.4b | AU$54.7b | AU$4.2b | 29x | 53.7x | 4.1x |
| Tue, 26 Jul 2022 | AU$220.9b | AU$53.9b | AU$4.8b | 24x | 45.8x | 4.1x |
Price to Earnings Ratio
45.8x
Current Industry PE
- Investors are pessimistic on the Australian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 63.4x which is lower than its 3-year average PE of 69.9x.
- The industry is trading close to its 3-year average PS ratio of 3.7x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 4.0% per year over the last three years.
- Meanwhile revenues for these companies have grown 10.0% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the Australian Healthcare sector?
| AU Market | 2.18% | |
| Healthcare | 4.55% | |
| Pharma | 11.26% | |
| Biotech | 7.16% | |
| Healthtech | 3.42% | |
| Medical Equipment | 2.83% | |
| Life Sciences | 1.52% | |
| Healthcare Services | -0.096% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry even though it's trading below its 3-year average PE ratio of 204x.
- Analysts are expecting annual earnings growth of 14.4%, which is lower than the prior year's growth of 19.6% per year.
Forecasted Growth
- Analysts are most optimistic on the Life Sciences industry, expecting annual earnings growth of 66% over the next 5 years.
- However this is lower than its past earnings growth rate of 88% per year.
- In contrast, the Biotech industry is expected to see its earnings grow by 14% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CSL CSL | AU$257.38 | 6.8% +AU$8.0b | -17.4% | PE29.6x | |
| PME Pro Medicus | AU$327.98 | 3.4% +AU$1.1b | 150.4% | PE348.6x | |
| MSB Mesoblast | AU$2.41 | 45.6% +AU$969.6m | 109.6% | PS354.7x | |
| COH Cochlear | AU$310.21 | 2.2% +AU$440.1m | -4.2% | PE54.8x | |
| TLX Telix Pharmaceuticals | AU$25.26 | 4.9% +AU$395.9m | 32.0% | PE171.2x |
